Prognostic Model Built on Blood-based Biomarkers in Patients with Metastatic Colorectal Cancer |
He, Wen-Zhuo
(Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine)
Jiang, Chang (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Yin, Chen-Xi (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Guo, Gui-Fang (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Rong, Ru-Ming (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Qiu, Hui-Juan (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Chen, Xu-Xian (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Zhang, Bei (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Xia, Liang-Ping (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) |
1 | An X, Ding PR, Li YH, et al (2010). Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers, 15, 516-22. DOI |
2 | Baba Y, Nosho K, Shima K, et al (2010). HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol, 176, 2292-301. DOI |
3 | Cao D, Hou M, Guan YS, et al (2009). Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer, 9, 432. DOI |
4 | Chiang SF, Hung HY, Tang R, et al (2012). Can neutrophil-tolymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? Int J Colorectal Dis, 27, 1347-57. DOI |
5 | Cohen SJ, Punt CJ, Iannotti N, et al (2008). Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol, 26, 3213-21. DOI ScienceOn |
6 | Farias IL, Farias JG, Rossato L, et al (2011). Correlation between TBARS levels and glycolytic enzymes: the importance to the initial evaluation of clinical outcome of colorectal cancer patients. Biomed Pharmacother, 65, 395-400. DOI |
7 | Franzini M, Corti A, Lorenzini E, et al (2006). Modulation of cell growth and cisplatin sensitivity by membrane gammaglutamyltransferase in melanoma cells. Eur J Cancer, 42, 2623-30. DOI |
8 | Franzini M, Bramanti E, Ottaviano V, et al (2008). A high performance gel filtration chromatography method for gamma-glutamyltransferase fraction analysis. Anal Biochem, 374, 1-6. DOI |
9 | Franzini M, Corti A, Fornaciari I, et al (2009). Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT. Biomarkers, 14, 486-92. DOI |
10 | Goldstein MJ, Mitchell EP (2005). Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest, 23, 338-51. DOI ScienceOn |
11 | He W, Yin C, Guo G, et al (2013). Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol, 30, 439. DOI ScienceOn |
12 | He WZ, Guo GF, Yin CX, et al (2013). Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer. Colorectal Dis, 15, 443-52. DOI |
13 | Kemal Y, Yucel I, Ekiz K, et al (2014). Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis. Asian Pac J Cancer Prev, 15, 2651-4. 과학기술학회마을 DOI ScienceOn |
14 | Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL (2006). Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the tumour angiogenesis research group. J Clin Oncol, 24, 4301-8. DOI ScienceOn |
15 | Kwon HC, Kim SH, Oh SY, et al (2012). Clinical significance of preoperative neutrophil-lymphocyte versus plateletlymphocyte ratio in patients with operable colorectal cancer. Biomarkers, 17, 216-22. DOI ScienceOn |
16 | Ozdemir Y, Akin ML, Sucullu I, Balta AZ, Yucel E (2014). Pretreatment neutrophil/lymphocyte ratio as a prognostic aid in colorectal cancer. Asian Pac J Cancer Prev, 15, 2647-50. 과학기술학회마을 DOI ScienceOn |
17 | Tokarz P, Blasiak J (2012). The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Acta Biochim Pol, 59, 467-74. |
18 | Pompella A, De Tata V, Paolicchi A, Zunino F (2006). Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance. Biochem Pharmacol, 71, 231-8. DOI |
19 | Saif MW, Alexander D, Wicox CM (2005). Serum alkaline phosphatase level as a prognostic tool in colorectal cancer: a study of 105 patients. J Appl Res, 5, 88-95. |
20 | Shiono S, Ishii G, Nagai K, et al (2006). Immunohistochemical prognostic factors in resected colorectal lung metastases using tissue microarray analysis. Eur J Surg Oncol, 32, 308-9. DOI ScienceOn |
21 | Xie Y, Wei ZB, Duan XW (2014). Prognostic value of pretreatment serum alkaline phosphatase in nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 15, 3547-53. 과학기술학회마을 DOI |
22 | Yang XQ, Chen C, Wang FB, Peng CW, Li Y (2011). Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer. Asian Pac J Cancer Prev, 12, 1251-6. |
23 | Noike T, Miwa S, Soeda J, Kobayashi A, Miyagawa S (2008). Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer. Hum Pathol, 39, 201-8. DOI |